Frank Witney has been named chief commercial officer at Affymetrix. As CCO, Witney is charged with integrating the commercial teams of Affy and its recently acquired companies, Panomics, True Materials, and USB.
Witney joined Panomics, formerly Genospectra, as CEO in 2002. Prior to that, he served as president of drug discovery tools at PerkinElmer Life sciences.
Witney was a postdoc fellow at the National Institutes of Health and holds a PhD in molecular and cell biology from Indiana University.